MOVE IT: Social Incentives to Increase Mobility

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT03321279
Collaborator
(none)
233
1
2
19.9
11.7

Study Details

Study Description

Brief Summary

This study aims to assess the effectiveness of a social incentive-based gamification intervention to increase physical activity in the 3 months after hospital discharge.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Social Incentive
N/A

Detailed Description

This study aims to assess the effectiveness of a social incentive-based gamification intervention to increase physical activity in the 3 months after hospital discharge. To do this, the investigators will conduct a two-arm randomized, controlled trial during the 3-months after hospital discharge comparing a control group that uses a wearable device to track physical activity to an intervention group that uses the same wearable devices and receives a supportive social incentive-based gamification intervention to adhere to a step goal program. Patients will be enrolled during hospitalization from medicine and oncology floors into three phases. In phase 1 (hospitalization), patients inpatient step counts will be monitored. In phase 2 (week 1 post-discharge), patients will have a baseline step count estimated. In phase 3 (weeks 2-13 post-discharge), patients will be randomly assigned to the control or intervention group. Patients will be considered enrolled in the trial if they complete the run-in periods (phases 1 and 2) and then are randomized into phase 3.

The enrollment phase will be part of another randomized trial which evaluates the impact of three recruitment strategies on patient enrollment. This trial will be completed and unmasked to patients before they begin the phase 1 of our study.

The investigators will also explore patients' physical activity while in the hospital and if that differs across floors that have or have not deployed a nursing mobility protocol. Changes in patient functional decline and 30-day hospital readmission will also be explored.

Study Design

Study Type:
Interventional
Actual Enrollment :
233 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Social Incentives to Increase Mobility Among Hospitalized Patients: The MOVE IT Randomized Trial
Actual Study Start Date :
Jan 11, 2018
Actual Primary Completion Date :
Sep 9, 2019
Actual Study Completion Date :
Sep 9, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Participants' daily step counts will be for weeks 2-13 after hospital discharge. Participants will be asked to complete surveys at 5, 9 and 13 weeks post-discharge.

Experimental: Intervention

Participants' daily step counts will be monitored for weeks 2-13 after hospital discharge. Participants will have a weekly step goal that increases from baseline by 10% each week of the intervention (12 weeks). Participants will engage in a social incentive-based gamification based on points and levels that leverages loss aversion, which has been demonstrated to motivate behavior change more effectively with losses than gains. Participants will receive daily feedback for the step counts and weekly feedback for levels. Participants will be asked to identify a support partner, who will receive weekly reports with the the participant's points and levels balance.

Behavioral: Social Incentive
Participants in the intervention arm will receive social incentives as part of the intervention. See arm descriptions for more detail.

Outcome Measures

Primary Outcome Measures

  1. Change in mean daily step count from the baseline period to the intervention period, using a wearable pedometer (Nokia Steel) to measure step count. [13 weeks]

    The primary outcome variable is the change in mean daily step count from the baseline period (week 1 post-discharge) to the intervention period (weeks 2-13 post-discharge). This will be measured using the Nokia Steel wearable device. .

Secondary Outcome Measures

  1. 30-day hospital readmission post-discharge, using the state's hospital database [13 weeks]

    A secondary outcome variable is 30-day hospital readmission post-discharge, which will be obtained from the state-based registry.

  2. Functional decline from admission to 3 months post-discharge, measured using validated survey assessments. [13 weeks]

    A secondary outcome variable is functional decline from admission to 3 months post-discharge, which will be obtained from information collected through validated survey assessments.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 or older

  • Admitted to medicine or oncology floor in the hospital

Exclusion Criteria:
  • Inability to provide informed consent

  • Does not have daily access to a smartphone compatible with the wearable device

  • Already enrolled in another physical activity program

  • Inpatient mobility score of 0 or 1 indicating that physical activity is not appropriate for the patient

  • Any other medical conditions that would prohibit participation in a 3-month physical activity program

  • Unable to complete the run-in phases (e.g. not discharged from the hospital within 60 days of enrolling; not willing to use the wearable device for the 3-month post-discharge intervention).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Pennsylvania

Investigators

  • Principal Investigator: Ryan Greysen, MD, MHS, MA, University of Pennsylvania
  • Study Director: Mitesh Patel, MD, MBA, MS, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT03321279
Other Study ID Numbers:
  • 826974
First Posted:
Oct 25, 2017
Last Update Posted:
Jul 30, 2020
Last Verified:
Jul 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 30, 2020